AOSEPT Products for Contact Lens Hygiene
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the long-term safety and effectiveness of two contact lens cleaning systems, AOSEPT Plus and AOSEPT Plus with HydraGlyde, for children who wear contact lenses. Participants will use these products with their usual contact lenses for 90 days. It suits children who have worn daily reusable soft or rigid gas permeable (RGP) contact lenses for at least 8 hours a day, five days a week, over the past three months. As an unphased trial, this study offers a unique opportunity for participants to contribute to research that could enhance contact lens care for children.
Do I need to stop my current medications for the trial?
The trial requires that you do not use any systemic or eye medications that would interfere with wearing contact lenses. If you are using any eye drops or medications that affect your eyes, you may need to stop them to participate.
What prior data suggests that these contact lens cleaning systems are safe for children?
Research has shown that AOSEPT Plus and AOSEPT Plus with HydraGlyde are generally safe for contact lens users. These preservative-free solutions clean and disinfect lenses effectively. However, careful use is crucial. They contain hydrogen peroxide, which can irritate or harm eyes if misused. Improper handling or inadequate rinsing of lenses has led to reports of pain, blurry vision, and redness. Despite these reports, both products are approved for use with contact lenses, indicating safety when used as directed. Always follow the product instructions to minimize risks.12345
Why are researchers excited about this trial?
Researchers are excited about these treatments because AOSEPT Plus and AOSEPT Plus with HydraGlyde offer a unique approach to contact lens hygiene. Unlike traditional multipurpose solutions, which clean and disinfect in one step, AOSEPT uses a hydrogen peroxide-based system that provides a deep clean by breaking down into water and oxygen, leaving no preservatives that can irritate the eyes. The addition of HydraGlyde in one of the treatments offers enhanced moisture retention for the lenses, potentially improving comfort for wearers. This combination of thorough cleaning and added moisture sets these treatments apart from standard lens care options.
What evidence suggests that this trial's treatments could be effective for contact lens hygiene?
Research has shown that AOSEPT Plus, one of the treatments in this trial, effectively cleans and disinfects contact lenses using hydrogen peroxide. It helps lenses remain comfortable longer by enhancing their ability to stay wet over time. AOSEPT Plus has been proven to deactivate harmful organisms like Acanthamoeba, which can cause problems if not properly controlled.
AOSEPT Plus with HydraGlyde, another treatment option in this trial, provides the same cleaning benefits while also helping lenses retain moisture. This means lenses can feel fresher and more comfortable throughout the day. Both solutions are designed to thoroughly clean and kill bacteria without added preservatives.56789Who Is on the Research Team?
Clinical Trial Lead, Vision Care
Principal Investigator
Alcon Research, LLC
Are You a Good Fit for This Trial?
This clinical trial is for children who use contact lenses and need a cleaning and disinfecting system. The specific eligibility criteria are not provided, but typically participants must be in good general health with no eye conditions that would interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use AOSEPT Plus or AOSEPT Plus with HydraGlyde with habitual contact lenses for 90 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- AOSEPT Plus
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alcon Research
Lead Sponsor
Raquel C. Bono
Alcon Research
Chief Medical Officer since 2022
MD from Harvard Medical School
David Endicott
Alcon Research
Chief Executive Officer since 2018
MBA from University of Southern California